ZIVO Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:ZIVO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Oct 24BuyUS$99,966John PayneIndividual6,343US$15.76
16 Oct 24BuyUS$49,993Laith YaldooIndividual3,133US$15.96
22 Aug 24BuyUS$261,342Christopher MaggioreIndividual31,336US$8.34
22 Aug 24BuyUS$99,997Alison CornellIndividual11,990US$8.34
26 Jul 24BuyUS$16,744Christopher MaggioreIndividual2,080US$8.05
12 Jun 24BuyUS$29,999Christopher MaggioreIndividual3,764US$7.97
02 Jan 24BuyUS$49,999Alison CornellIndividual41,666US$1.20
29 Dec 23BuyUS$205,000Christopher MaggioreIndividual157,692US$1.30
13 Dec 23BuyUS$45,000Christopher MaggioreIndividual45,000US$1.00

Insider Trading Volume

Insider Buying: ZIVO insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ZIVO?
Owner TypeNumber of SharesOwnership Percentage
Institutions57,5061.62%
VC/PE Firms530,98915%
General Public1,338,03437.7%
Individual Insiders1,619,80645.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 94.9%.


Top Shareholders

Top 9 shareholders own 62.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
Laith Yaldoo
533,424US$10.0m0.59%no data
15%
HEP Investments, LLC
530,989US$10.0m0%no data
14.1%
Christopher Maggiore
498,443US$9.4m7.19%no data
7.27%
Alison Cornell
257,975US$4.8m4.87%no data
5.6%
Mark Strome
198,644US$3.7m0%no data
3.44%
Nola Masterson
122,024US$2.3m0%no data
1.62%
Strome Investment Management, L.P.
57,506US$1.1m0%11.42%
0.22%
John Payne
7,909US$148.5k405%no data
0.039%
Andrew Dahl
1,387US$26.0k0%no data